Ortho Kinematics: 23 patients enrolled in KineGraph VMA clinical study

NewsGuard 100/100 Score

Ortho Kinematics, a privately held spine diagnostics company focused on revolutionizing spine motion analysis, announced today that it has begun a multi-site clinical study of the KineGraph VMA™, and that the initial 23 patients have been enrolled. The study will help determine which types of patients are best evaluated with KineGraph VMA testing. The KineGraph VMA is designed to provide functional diagnostic information to spine surgeons to be used in conjunction with MRI and plain X-rays.

“Our previous clinical studies demonstrated proof of concept and validated the potential of our technology. We are now embarking on a trial to demonstrate the potential of our test to provide additional information for surgical decisions”

"The KineGraph VMA study is designed to provide a large set of spine biomechanics data across a wide variety of surgical patients. We hope to use the insights gained from this study to further understand back pain," said Antonio Castellvi, M.D., an orthopaedic spine surgeon at the Florida Orthopaedic Institute who is an investigator in the study. In addition to Dr. Castellvi, several other leading US spine surgeons and institutions will be participating in the study.

The Kinegraph VMA is an investigational technology that provides clinicians with biomechanical data to help them assess spine function. Pilot studies have demonstrated the technology's potential to identify adjacent level disease risk, inter-vertebral stiffness, laxity, paradoxical motion and other related parameters of a patient's spinal column motion.

"Our previous clinical studies demonstrated proof of concept and validated the potential of our technology. We are now embarking on a trial to demonstrate the potential of our test to provide additional information for surgical decisions," added Adam Deitz, CEO of Ortho Kinematics.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals optimal drug sequencing for postmenopausal osteoporosis treatment